Journal for ImmunoTherapy of Cancer (Nov 2020)
96 Decitabine gene modulation sensitizes human non–small cell lung cancer (NSCLC) to NY-ESO-1 TCR immunotherapy (letetresgene autoleucel; GSK3377794) in vivo
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)